Details for New Drug Application (NDA): 217553
✉ Email this page to a colleague
The generic ingredient in POSACONAZOLE is posaconazole. There are twenty-one drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the posaconazole profile page.
Summary for 217553
Tradename: | POSACONAZOLE |
Applicant: | Gland Pharma Ltd |
Ingredient: | posaconazole |
Patents: | 0 |
Suppliers and Packaging for NDA: 217553
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POSACONAZOLE | posaconazole | SOLUTION;INTRAVENOUS | 217553 | ANDA | Gland Pharma Limited | 68083-577 | 68083-577-01 | 1 VIAL in 1 CARTON (68083-577-01) / 16.7 mL in 1 VIAL |
POSACONAZOLE | posaconazole | SOLUTION;INTRAVENOUS | 217553 | ANDA | GLENMARK PHARMACEUTICALS INC., USA | 68462-904 | 68462-904-01 | 1 VIAL in 1 CARTON (68462-904-01) / 16.7 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 300MG/16.7ML (18MG/ML) | ||||
Approval Date: | Dec 26, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription